Spain’s royals honor Asturias prize winners, including Meryl Streep and Haruki Murakami
Published Sat, 22 Feb 2025 09:44:07 GMT
Alberta livestock producers affected by drought to receive aid to offset costs
Published Sat, 22 Feb 2025 09:44:07 GMT
Navigator cancels proposed Midwestern CO2 pipeline, citing ‘unpredictable’ regulatory processes
Published Sat, 22 Feb 2025 09:44:07 GMT
Man arrested, warrant issued for second man in alleged mortgage fraud in Brampton
Published Sat, 22 Feb 2025 09:44:07 GMT
DeSantis allies ask Florida judge to throw out Disney’s counterclaims in lawsuit
Published Sat, 22 Feb 2025 09:44:07 GMT
Juveniles charged with dousing acid on playground slides that injured 4 children
Published Sat, 22 Feb 2025 09:44:07 GMT
Mother, daughter from Evanston who were held hostage by Hamas have been released
Published Sat, 22 Feb 2025 09:44:07 GMT
House Republicans look for reset after Jordan loses Speaker fight: Live coverage
Published Sat, 22 Feb 2025 09:44:07 GMT
Austin-Johnson Airport? Mayor in talks to possibly rename AUS after former president
Published Sat, 22 Feb 2025 09:44:07 GMT
House unveils plan for school funding, education savings accounts
Published Sat, 22 Feb 2025 09:44:07 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says